Want to see FR:BIM full AI Analyst Report?

bioMerieux (BIM) Ratios

12 Followers

bioMerieux Ratios

FR:BIM's free cash flow for Q2 2026 was €0.55. For the 2026 fiscal year, FR:BIM's free cash flow was decreased by € and operating cash flow was €0.15. See a summary of the company’s cash flow.

Ratios	TTM	Dec 25	Dec 24	Dec 23	Dec 22
Liquidity Ratios
Current Ratio	2.30	2.39	2.20	2.03	1.96
Quick Ratio	1.44	1.47	1.29	1.19	1.28
Cash Ratio	0.58	0.54	0.40	0.32	0.49
Solvency Ratio	0.65	0.57	0.47	0.41	0.46
Operating Cash Flow Ratio	0.80	0.74	0.59	0.41	0.42
Short-Term Operating Cash Flow Coverage	4.52	7.94	5.98	3.27	2.95
Net Current Asset Value	€ 1.20B	€ 1.07B	€ 942.10M	€ 698.20M	€ 673.00M
Leverage Ratios
Debt-to-Assets Ratio	0.07	0.08	0.09	0.10	0.10
Debt-to-Equity Ratio	0.10	0.11	0.12	0.14	0.14
Debt-to-Capital Ratio	0.09	0.10	0.10	0.12	0.12
Long-Term Debt-to-Capital Ratio	0.02	0.05	0.05	0.06	0.06
Financial Leverage Ratio	1.33	1.36	1.37	1.40	1.44
Debt Service Coverage Ratio	3.69	7.57	5.82	4.18	4.26
Interest Coverage Ratio	57.63	35.52	36.80	99.80	136.54
Debt to Market Cap	0.03	0.02	0.03	0.03	0.03
Interest Debt Per Share	3.65	4.05	4.30	4.43	4.32
Net Debt to EBITDA	-0.26	-0.11	0.05	0.24	-0.06
Profitability Margins
Gross Profit Margin	52.04%	52.63%	55.66%	55.99%	54.64%
EBIT Margin	11.99%	13.79%	14.96%	12.03%	15.44%
EBITDA Margin	22.98%	24.56%	22.55%	19.08%	22.62%
Operating Profit Margin	11.99%	13.79%	14.79%	11.95%	15.60%
Pretax Profit Margin	15.21%	12.91%	14.56%	11.91%	15.33%
Net Profit Margin	11.59%	9.77%	10.86%	9.73%	12.60%
Continuous Operations Profit Margin	11.58%	9.75%	10.68%	8.79%	12.27%
Net Income Per EBT	76.18%	75.64%	74.61%	81.74%	82.22%
EBT Per EBIT	126.91%	93.64%	98.39%	99.64%	98.29%
Return on Assets (ROA)	8.12%	7.13%	7.49%	6.80%	8.72%
Return on Equity (ROE)	11.01%	9.69%	10.28%	9.53%	12.55%
Return on Capital Employed (ROCE)	10.48%	12.44%	12.70%	10.53%	13.80%
Return on Invested Capital (ROIC)	7.59%	9.13%	9.04%	7.48%	10.56%
Return on Tangible Assets	10.23%	8.94%	9.50%	8.87%	15.41%
Earnings Yield	5.48%	3.06%	3.55%	3.01%	3.92%
Efficiency Ratios
Receivables Turnover	4.15	4.29	4.64	4.25	4.15
Payables Turnover	7.59	7.36	6.48	6.10	6.04
Inventory Turnover	1.96	1.98	1.70	1.78	2.12
Fixed Asset Turnover	2.34	2.46	2.35	2.44	2.62
Asset Turnover	0.70	0.73	0.69	0.70	0.69
Working Capital Turnover Ratio	2.71	2.86	3.20	3.34	3.10
Cash Conversion Cycle	225.93	220.05	236.87	231.16	199.66
Days of Sales Outstanding	88.00	85.04	78.65	85.97	87.99
Days of Inventory Outstanding	186.01	184.64	214.56	205.02	172.07
Days of Payables Outstanding	48.08	49.62	56.34	59.83	60.40
Operating Cycle	274.01	269.68	293.21	290.99	260.06
Cash Flow Ratios
Operating Cash Flow Per Share	7.71	6.68	5.67	3.77	4.03
Free Cash Flow Per Share	4.97	3.84	2.73	0.91	1.60
CapEx Per Share	2.74	2.84	2.94	2.87	2.43
Free Cash Flow to Operating Cash Flow	0.65	0.57	0.48	0.24	0.40
Dividend Paid and CapEx Coverage Ratio	2.08	1.79	1.50	1.02	1.22
Capital Expenditure Coverage Ratio	2.82	2.35	1.93	1.32	1.66
Operating Cash Flow Coverage Ratio	2.15	1.71	1.36	0.86	0.94
Operating Cash Flow to Sales Ratio	0.23	0.19	0.17	0.12	0.13
Free Cash Flow Yield	6.93%	3.48%	2.64%	0.90%	1.63%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	18.22	32.73	28.20	33.21	25.53
Price-to-Sales (P/S) Ratio	2.12	3.20	3.06	3.23	3.22
Price-to-Book (P/B) Ratio	1.96	3.17	2.90	3.17	3.20
Price-to-Free Cash Flow (P/FCF) Ratio	14.43	28.72	37.91	110.89	61.30
Price-to-Operating Cash Flow Ratio	9.29	16.50	18.27	26.66	24.31
Price-to-Earnings Growth (PEG) Ratio	0.79	-4.00	1.34	-1.57	-1.05
Price-to-Fair Value	1.96	3.17	2.90	3.17	3.20
Enterprise Value Multiple	8.95	12.91	13.63	17.17	14.17
Enterprise Value	8.21B	12.90B	12.23B	12.04B	11.50B
EV to EBITDA	8.95	12.91	13.63	17.17	14.17
EV to Sales	2.06	3.17	3.07	3.28	3.20
EV to Free Cash Flow	14.03	28.48	38.04	112.44	61.05
EV to Operating Cash Flow	9.05	16.37	18.33	27.04	24.21
Tangible Book Value Per Share	26.55	25.24	25.38	21.39	11.81
Shareholders’ Equity Per Share	36.49	34.78	35.71	31.78	30.56
Tax and Other Ratios
Effective Tax Rate	0.24	0.25	0.27	0.26	0.20
Revenue Per Share	33.89	34.50	33.80	31.13	30.43
Net Income Per Share	3.93	3.37	3.67	3.03	3.84
Tax Burden	0.76	0.76	0.75	0.82	0.82
Interest Burden	1.27	0.94	0.97	0.99	0.99
Research & Development to Revenue	0.13	0.12	0.12	0.13	0.12
SG&A to Revenue	0.27	0.27	0.28	0.08	0.07
Stock-Based Compensation to Revenue	0.00	<0.01	<0.01	<0.01	<0.01
Income Quality	1.96	1.98	1.57	1.25	1.05

Currency in EUR